Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000152691 | SCV000169831 | benign | not specified | 2014-06-09 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Laboratory for Molecular Medicine, |
RCV000152691 | SCV000202065 | benign | not specified | 2012-05-07 | criteria provided, single submitter | clinical testing | Ile720Val in Exon 08 of WFS1: This variant is not expected to have clinical sign ificance because it has been identified in 12.2% (11/90) of chromosomes from a p opulation in the dbSNP database (http://www.ncbi.nlm.nih.gov/projects/SNP; rs180 5070). |
Prevention |
RCV000152691 | SCV000311321 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000263623 | SCV000450657 | likely benign | WFS1-Related Spectrum Disorders | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
Eurofins Ntd Llc |
RCV000152691 | SCV000706605 | benign | not specified | 2017-02-24 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000756928 | SCV000884915 | benign | not provided | 2023-02-22 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000756928 | SCV001005748 | benign | not provided | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV001174426 | SCV001337564 | benign | Monogenic diabetes | 2019-01-25 | criteria provided, single submitter | research | ACMG criteria: BA1 (5.7% in gnomAD East Asian, 2.1% in EurF), BS2 (32 homozygotes in gnomAD)=benign (REVEL 0.433 + PP3/3 predictors + BP4/7 predictors= conflicting evidence, not using) |
Clinical Genomics, |
RCV002285142 | SCV002574792 | benign | Diabetes mellitus | criteria provided, single submitter | research | Potent mutations of WFS1 gene are associated with Wolfram's syndrome, an autosomal recessive condition, which cause diabetes mellitus, diabetes insipidus, deafness and optic atrophy. Though rs1805070 is prevalent in Type I Diabetes Mellitus cases, more evidence is required to ascertain the significance. | |
Fulgent Genetics, |
RCV002498615 | SCV002809039 | likely benign | Cataract 41; Wolfram syndrome 1; Autosomal dominant nonsyndromic hearing loss 6; Type 2 diabetes mellitus; Wolfram-like syndrome | 2021-11-01 | criteria provided, single submitter | clinical testing |